fda glp-1 safety warning september 2025 NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP -1 Weight Loss Drugs FDA Sends Warning Letters to

Dosage and Duration of Use: Someone on a higher maintenance dose who has been on the medication for a year will have a more established steady-state concentration than someone who only took a low starting dose for a few weeks

Storage by form - does it affect your effective dose

Monthly during use: Self-examine all moles using the ABCDE criteria: - A symmetry: One half does not match the other - B order: Edges are irregular, ragged, or blurred - C olor: Uneven color with shades of brown, black, red, white, or blue - D iameter: Larger than 6 mm (the size of a pencil eraser) - E volving: Any change in size, shape, color, elevation, or any new symptom (bleeding, itching, crusting) 3

This is a summary, not a complete list of precautions, and it is not medical advice, so talk with your provider or pharmacist about your specific situation

doi: 10.1038/s41591-024-02996-7